Q2 FY27 · NSE: ACUTAAS
Acutaas Chemicals
Results filed 27 October 2026 · Market cap ₹32,778 crore · PE 74.6
- Revenue
- +42.7%
- on a year ago
- EBITDA
- +84.6%
- on a year ago
- Profit to shareholders
- +73.3%
- on a year ago
- EBITDA margin
- 40.3%
- +6.0 pts on last quarter
| Q2 FY27 | Q1 FY27 | vs previous quarter | Q2 FY26 | vs a year ago | |
|---|---|---|---|---|---|
| Revenue | 437 | 330 | +32.5% | 306 | +42.7% |
| Operating profit (EBIT) | 163 | 103 | +58.2% | 86.93 | +87.8% |
| Operating margin | 37.4% | 31.3% | +606 bps | 28.4% | +898 bps |
| Other income | 5.1 | 1.8 | +183.3% | 9.84 | −48.2% |
| Exceptional items | 0 | 0 | – | 0 | – |
| Profit before exceptional items and tax | 167 | 104 | +61.1% | 96.18 | +74.0% |
| Profit to shareholders | 125 | 74.26 | +68.6% | 72.24 | +73.3% |
| Earnings per share (₹) | 15.29 | 9.07 | +68.6% | 8.82 | +73.4% |
Source: Acutaas Chemicals Limited’s filing to NSE, 27 October 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.
Notes
No notes yet. They are written once the investor presentation or concall transcript is filed; transcripts usually come three to seven days after the call.
Sources
- Press release · filed 27-Oct-2026
- Investor presentation · filed 27-Oct-2026
- Figures: the company’s results filing with NSE, linked under the table.